Hippo Dx

Belgium Founded: 2020 • Age: 6 yrs
Developer of a medical device to provide an automated test that detects allergies
Request Access

About Hippo Dx

Hippo Dx is a company based in Belgium founded in 2020 by Wim Hofkens and Peter Deroovere.. Hippo Dx has raised $4.67 million across 2 funding rounds from investors including AllerFund, LRM and imec.istart. The company has 6 employees as of December 31, 2022. Hippo Dx offers products and services including S.P.A.T.. Hippo Dx operates in a competitive market with competitors including SetPoint Medical, Boomerang Medical, Therakos, Labseed and TheraLight, among others.

  • Headquarter Belgium
  • Employees 6 as on 31 Dec, 2022
  • Founders Wim Hofkens, Peter Deroovere
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Hippocreates
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $4.67 M (USD)

    in 2 rounds

  • Latest Funding Round
    $4.61 M (USD), Series A

    Oct 04, 2023

  • Investors
    AllerFund

    & 2 more

  • Employee Count
    6

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Hippo Dx

Hippo Dx offers a comprehensive portfolio of products and services, including S.P.A.T.. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Automated tool for performing skin prick tests in allergy diagnosis.

Funding Insights of Hippo Dx

Hippo Dx has successfully raised a total of $4.67M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.61 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $4.6M
  • First Round

    (01 Jun 2020)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2023 Amount Series A - Hippo Dx Valuation AllerFund , LRM
Jun, 2020 Amount Seed - Hippo Dx Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Hippo Dx

Hippo Dx has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include AllerFund, LRM and imec.istart. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture capital investments are focused on food allergy solutions.
Founded Year Domain Location
LRM is engaged in providing risk capital and smart money to businesses in Limburg.
Founded Year Domain Location
Funding solutions for tech startups are provided by the accelerator.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Hippo Dx

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Hippo Dx

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Hippo Dx Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Hippo Dx

Hippo Dx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SetPoint Medical, Boomerang Medical, Therakos, Labseed and TheraLight, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Implantable neuromodulation devices are developed for inflammatory diseases.
domain founded_year HQ Location
Bioelectronic devices are developed for autoimmune disease treatment.
domain founded_year HQ Location
Therakos is focused on photopheresis systems for CTCL treatment.
domain founded_year HQ Location
Technology to suppress capsular contraction is developed.
domain founded_year HQ Location
Provides red light therapy beds to promote cellular health and reduce oxidative stress.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Hippo Dx

Frequently Asked Questions about Hippo Dx

When was Hippo Dx founded?

Hippo Dx was founded in 2020.

Where is Hippo Dx located?

Hippo Dx is headquartered in Belgium.

Is Hippo Dx a funded company?

Hippo Dx is a funded company, having raised a total of $4.67M across 2 funding rounds to date. The company's 1st funding round was a Seed of $61.36K, raised on Jun 01, 2020.

How many employees does Hippo Dx have?

As of Dec 31, 2022, the latest employee count at Hippo Dx is 6.

What does Hippo Dx do?

Developer of a medical device to provide an automated test that detects allergies. It offers S.P.A.T. that assists doctors and medical personnel in the diagnosis and treatment of chronic conditions and pathologies based on robotics and artificial intelligence technologies.

Who are the top competitors of Hippo Dx?

Hippo Dx's top competitors include SetPoint Medical, Boomerang Medical and Therakos.

What products or services does Hippo Dx offer?

Hippo Dx offers S.P.A.T..

Who are Hippo Dx's investors?

Hippo Dx has 3 investors. Key investors include AllerFund, LRM, and imec.istart.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available